{"id":584,"date":"2024-07-01T12:09:41","date_gmt":"2024-07-01T10:09:41","guid":{"rendered":"https:\/\/www.everpharma.com\/esp\/?post_type=product&#038;p=584"},"modified":"2024-07-01T12:09:41","modified_gmt":"2024-07-01T10:09:41","slug":"bortezomib","status":"publish","type":"product","link":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/","title":{"rendered":"Bortezomib"},"content":{"rendered":"\n<div class=\"wp-block-group meta\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<figure class=\"wp-block-table product-data-table\"><table><tbody><tr><td><strong>Forma farmac\u00e9utica<\/strong><\/td><td>Soluci\u00f3n inyectable<\/td><\/tr><tr><td><strong>D\u00f3sis<\/strong><\/td><td>2.5 mg\/ml<\/td><\/tr><tr><td><strong>D\u00f3sis por unidad<\/strong><\/td><td>2.5 mg\/1.0 ml<\/td><\/tr><tr><td><strong>C\u00f3digo ATC<\/strong><\/td><td>L01XG01<\/td><\/tr><tr><td><strong>Clase Medicamento<\/strong><\/td><td>Otros agentes antineopl\u00e1sicos e inhibidores del proteosoma<\/td><\/tr><tr><td><strong>Indicaci\u00f3n<\/strong><\/td><td>Bortezomib en monoterapia, o en combinaci\u00f3n con doxorubicina liposomal pegilada o con dexametasona, est\u00e1 indicado para el tratamiento de pacientes adultos con mieloma m\u00faltiple en progresi\u00f3n que han recibido previamente al menos 1 tratamiento y que han sido sometidos o no son candidatos a trasplante de progenitores hematopoy\u00e9ticos.<br>&nbsp;<br>Bortezomib est\u00e1 indicado en combinaci\u00f3n con melfal\u00e1n y prednisona, en el tratamiento de pacientes adultos con mieloma m\u00faltiple que no han sido previamente tratados y que no sean candidatos a recibir tratamiento con altas dosis de quimioterapia previo a un trasplante de progenitores hematopoy\u00e9ticos.<br>&nbsp;<br>Bortezomib est\u00e1 indicado en combinaci\u00f3n con dexametasona, o con dexametasona y talidomida, en el tratamiento de inducci\u00f3n de pacientes adultos con mieloma m\u00faltiple que no han sido previamente tratados y que sean candidatos a recibir tratamiento con altas dosis de quimioterapia previo a un trasplante de progenitores hematopoy\u00e9ticos.<br>Bortezomib est\u00e1 indicado en combinaci\u00f3n con rituximab, ciclofosfamida, doxorubicina y prednisona en el tratamiento de pacientes adultos con linfoma de c\u00e9lulas del manto que no han sido previamente tratados y que no sean considerados apropiados para un trasplante de progenitores hematopoy\u00e9ticos<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" data-id=\"601\" src=\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg\" alt=\"\" class=\"wp-image-601\" srcset=\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg 1024w, https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-300x300.jpg 300w, https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-150x150.jpg 150w, https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-768x768.jpg 768w, https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib.jpg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><em>La informaci\u00f3n detallada y actualizada de este medicamento est\u00e1 disponible en la p\u00e1gina Web de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) http:\/\/www.aemps.gob.es\/<\/em><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-base-font-size\"><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Forma farmac\u00e9utica Soluci\u00f3n inyectable D\u00f3sis 2.5 mg\/ml D\u00f3sis por unidad 2.5 mg\/1.0 ml C\u00f3digo ATC L01XG01 Clase Medicamento Otros agentes antineopl\u00e1sicos e inhibidores del proteosoma Indicaci\u00f3n Bortezomib en monoterapia, o en combinaci\u00f3n con doxorubicina liposomal pegilada o con dexametasona, est\u00e1 indicado para el tratamiento de pacientes adultos con mieloma m\u00faltiple en progresi\u00f3n que han recibido &hellip; <a href=\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\">Continued<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-584","product","type-product","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bortezomib - EVER Pharma Spain<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bortezomib - EVER Pharma Spain\" \/>\n<meta property=\"og:description\" content=\"Forma farmac\u00e9utica Soluci\u00f3n inyectable D\u00f3sis 2.5 mg\/ml D\u00f3sis por unidad 2.5 mg\/1.0 ml C\u00f3digo ATC L01XG01 Clase Medicamento Otros agentes antineopl\u00e1sicos e inhibidores del proteosoma Indicaci\u00f3n Bortezomib en monoterapia, o en combinaci\u00f3n con doxorubicina liposomal pegilada o con dexametasona, est\u00e1 indicado para el tratamiento de pacientes adultos con mieloma m\u00faltiple en progresi\u00f3n que han recibido &hellip; Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\" \/>\n<meta property=\"og:site_name\" content=\"EVER Pharma Spain\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\",\"url\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\",\"name\":\"Bortezomib - EVER Pharma Spain\",\"isPartOf\":{\"@id\":\"https:\/\/www.everpharma.com\/esp\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg\",\"datePublished\":\"2024-07-01T10:09:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage\",\"url\":\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib.jpg\",\"contentUrl\":\"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.everpharma.com\/esp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Products\",\"item\":\"https:\/\/www.everpharma.com\/esp\/products\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bortezomib\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.everpharma.com\/esp\/#website\",\"url\":\"https:\/\/www.everpharma.com\/esp\/\",\"name\":\"EVER Pharma Spain\",\"description\":\"Dedicated to Health.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.everpharma.com\/esp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bortezomib - EVER Pharma Spain","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/","og_locale":"es_ES","og_type":"article","og_title":"Bortezomib - EVER Pharma Spain","og_description":"Forma farmac\u00e9utica Soluci\u00f3n inyectable D\u00f3sis 2.5 mg\/ml D\u00f3sis por unidad 2.5 mg\/1.0 ml C\u00f3digo ATC L01XG01 Clase Medicamento Otros agentes antineopl\u00e1sicos e inhibidores del proteosoma Indicaci\u00f3n Bortezomib en monoterapia, o en combinaci\u00f3n con doxorubicina liposomal pegilada o con dexametasona, est\u00e1 indicado para el tratamiento de pacientes adultos con mieloma m\u00faltiple en progresi\u00f3n que han recibido &hellip; Continued","og_url":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/","og_site_name":"EVER Pharma Spain","og_image":[{"url":"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/","url":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/","name":"Bortezomib - EVER Pharma Spain","isPartOf":{"@id":"https:\/\/www.everpharma.com\/esp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage"},"image":{"@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib-1024x1024.jpg","datePublished":"2024-07-01T10:09:41+00:00","breadcrumb":{"@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#primaryimage","url":"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib.jpg","contentUrl":"https:\/\/www.everpharma.com\/esp\/wp-content\/uploads\/sites\/6\/2024\/03\/12-Bortezomib.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.everpharma.com\/esp\/products\/bortezomib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.everpharma.com\/esp\/"},{"@type":"ListItem","position":2,"name":"Products","item":"https:\/\/www.everpharma.com\/esp\/products\/"},{"@type":"ListItem","position":3,"name":"Bortezomib"}]},{"@type":"WebSite","@id":"https:\/\/www.everpharma.com\/esp\/#website","url":"https:\/\/www.everpharma.com\/esp\/","name":"EVER Pharma Spain","description":"Dedicated to Health.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.everpharma.com\/esp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"}]}},"_links":{"self":[{"href":"https:\/\/www.everpharma.com\/esp\/wp-json\/wp\/v2\/product\/584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.everpharma.com\/esp\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.everpharma.com\/esp\/wp-json\/wp\/v2\/types\/product"}],"wp:attachment":[{"href":"https:\/\/www.everpharma.com\/esp\/wp-json\/wp\/v2\/media?parent=584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}